Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UK.

Publication date: Jul 01, 2025

Delivering research studies that require a large number of samples to monitor specific populations is complex, often resulting in high costs and intricate logistics. We aim to describe the processes for blood sample collection and management and evaluate alternative sampling methods within a large cohort of healthcare workers in the UK (the SIREN study). We conducted a process evaluation. First, we described blood sample collection and management across different study periods from June 2020 to March 2024 and how these evolved over time. Secondly, we compared alternative methods of blood sampling: venous phlebotomy (hospital-based) vs. capillary sampling (at-home). The main challenges with blood sampling within SIREN stemmed from the scale and use of decentralised phlebotomy across 135 hospital sites during the COVID-19 pandemic. We adapted our sampling processes as the study progressed, overcoming most of these challenges. When comparing hospital-based and at-home sampling, overall, return rates of samples taken at home were higher than site- based samples (80% vs 71%, respectively). At-home samples took less time to be returned to UKHSA Laboratory for testing compared to hospital-based samples (median 2 days; interquartile (IQ) 2-3) vs 6 days; IQ 3-8). However, at-home samples were more likely to be considered void (4%) when tested compared to hospital-based samples (0%). Cost for hospital-based sampling was almost 3-times higher than at-home sampling (lb34. 05 vs lb11. 50, respectively), although larger sample volumes were obtained via hospital-based sampling when compared to at-home sampling (8 ml vs 600 ul of whole blood). Sample collection and management in large scale research studies are complex. Our results support at-home blood sampling as an effective and cheaper strategy when compared to hospital-based phlebotomy and therefore should be considered as alternative sampling method for future research. ISRCTN11041050-registration date 12/01/2021.

Open Access PDF

Concepts Keywords
Healthcare Blood Specimen Collection
Isrctn11041050 Blood specimen collection
June Cohort Studies
Large Cohort studies
Phlebotomy COVID-19
Evaluation
Health Personnel
Humans
Pandemics
Phlebotomy
Phlebotomy
SARS-CoV-2
United Kingdom

Semantics

Type Source Name
disease IDO blood
disease IDO process
disease MESH COVID-19 pandemic
disease IDO site
pathway REACTOME Reproduction
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Coenzyme M
disease IDO emerging pathogen
disease IDO immunodeficiency
disease MESH infections
disease MESH STI
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH Reinfection
drug DRUGBANK Ademetionine
disease MESH bleeding
disease IDO assay
drug DRUGBANK Etoperidone
disease MESH tics
drug DRUGBANK Indoleacetic acid
disease IDO pathogen
disease MESH inflammation
disease MESH Arthritis
drug DRUGBANK Methyldopa
drug DRUGBANK Trestolone

Original Article

(Visited 7 times, 1 visits today)